Premium
Obstacles to improving outcomes in the treatment of uveal melanoma
Author(s) -
Tsai Katy K.,
Bollin Kathryn B.,
Patel Sapna P.
Publication year - 2018
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.31284
Subject(s) - medicine , melanoma , specialty , multidisciplinary approach , radiation oncology , clinical trial , cancer , pace , intensive care medicine , clinical oncology , radiation therapy , oncology , medical physics , family medicine , cancer research , social science , geodesy , sociology , geography
The rate of advances in uveal melanoma has not kept pace with the rate of advances in cutaneous melanoma. Many patients lack access to or knowledge of specialty centers, and integrated multidisciplinary care between ophthalmology, radiation oncology, and medical oncology is far from the norm. This treatment isolation leads to limited communication about novel clinical trial opportunities. Clinical trials themselves are not widely available, and a lack of robust funding limits rapid and complete investigations. This review outlines the obstacles to success in uveal melanoma management and highlights strategies for overcoming these challenges. Cancer 2018;124:2693‐2703 . © 2018 American Cancer Society